- My News
- All News
- Most Popular
Siemens Healthineers announced that it entered into a global agreement with HeartFlow to develop integrated, non-invasive care solutions for the improved management of patients with suspected coronary artery disease (CAD). The companies' joint solution will pair Siemens Healthineers' computed tomography (CT) scanners with the HeartFlow FFRct Analysis, which Siemens said is "the first non-invasive technology" to provide insight into the extent of CAD and the impact CAD has on blood flow to the heart.
"Treatment planning for coronary artery disease patients can be improved via quantitative data out of FFR [fractional flow reserve] measurements," said André Hartung, head of CT at Siemens Healthineers. With the partnership "we create an integrated solution that combines the exceptional cCTA [coronary computed tomography angiography] images acquired by our high performance scanners with the only commercial product available that can derive FFR analysis noninvasively from CT data," Hartung added.
Under the agreement, of which financial terms were not disclosed, Siemens and HeartFlow will initially focus on the US. The companies plan to expand their commercial efforts in the future to additional markets.
According to Siemens, using CT images, the HeartFlow FFRct Analysis creates a personalised 3D model of the patient's arteries, while computer algorithms simulate blood flow and measure the impact of arterial blockages, "helping physicians determine each patient’s optimal course of treatment." The HeartFlow FFRct Analysis is available in the US, Canada, Europe and Japan.
Did you like this article?